Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Conditions: Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Other: Fludeoxyglucose F-18; Other: Gallium Ga 68 Gozetotide; Drug: Lutetium Lu 177 Vipivotide Tetraxetan; Procedure: Positron Emission Tomography; Procedure: Single Photon Emission Computed Tomography; Drug: Vorinostat Sponsors: University of Washington; Novartis; Institute for Prostate Cancer Research (IPCR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials